| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 304.4 | 265.8 | 213.9 |
| Other income | 7.2 | 2.4 | 2.9 |
| Total income | 311.6 | 268.2 | 216.8 |
| Profit before exceptional items & tax | 17.0 | 5.7 | -0.3 |
| Exceptional items | 0.0 | 0.0 | 29.4 |
| Profit before tax | 17.0 | 5.7 | -29.8 |
| Net profit | 31.6 | 3.5 | -40.1 |
| Operating margin | 5.5% | 2.1% | -13.7% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, quarter on quarter | +802.90% |
|---|---|
| Revenue, year on year | +42.30% |
BSE results filing, NSE: KANORICHEM. Figures extracted from the filing.
Kanoria Chemicals & Industries Ltd: key numbers
- Share price
- ₹174.89
- Market cap
- ₹764.1 Cr
- Revenue (annual)
- ₹981.4 Cr
- Net profit (annual)
- ₹120.8 Cr
- P/E (TTM)
- 4.9×Sector 35.5×
- Promoter holding
- 74.40%+0.00% QoQ
- FII holding
- 0.07%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kanoria Chemicals & Industries Ltd
All →Kanoria Chemicals & Industries Board Meeting Date
Kanoria Chemicals & Industries gave advance notice that its Board will meet on 13 November 2026. Inter alia, it will consider approval of unaudited financial results for the September 2026 quarter and half year.
Kanoria Chemicals & Industries Other Announcement
Kanoria Chemicals & Industries Ltd submitted its quarterly shareholding pattern for the period ending September 30, 2026, as required under SEBI regulations.
Kanoria Chemicals & Industries Capacity Expansion
Kanoria Chemicals announced a new 12 TPD Triacetin manufacturing facility at its existing site in Ankleshwar, Gujarat, to strengthen its specialty chemicals portfolio.
- manufacturing capacity
- 12.0 TPD
Kanoria Chemicals & Industries Credit Rating
Infomerics rated Kanoria Chemicals' long-term bank facilities IVR BBB-/Stable and short-term facilities IVR A3. The rating covers a total of Rs.162.07 Crore in rated bank loan facilities.
Kanoria Chemicals & Industries Investor Presentation: Key Takeaways
Kanoria Chemicals reported strong FY26 performance with 30% consolidated revenue growth and 90% EBITDA growth. Management highlights operational efficiencies and a strategic 'Vision 2030' roadmap.
Kanoria Chemicals & Industries Annual General Meeting
Kanoria Chemicals & Industries Limited conducted its 66th Annual General Meeting on September 2, 2026, via video conferencing. The meeting covered routine ordinary and special business resolutions.